These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 23398286
21. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J, de Witte T, Ljungman P, McDonald F, McGrath E, Passweg J, Peters C, Rocha V, Slaper-Cortenbach I, Sureda A, Tichelli A, Apperley J. J Clin Oncol; 2011 May 20; 29(15):1980-6. PubMed ID: 21483006 [Abstract] [Full Text] [Related]
22. Implementation of JACIE accreditation results in the establishment of new indicators that unevenly monitor processes contributing to the delivery of hematopoietic SCT. Caunday O, Agulles O, McGrath E, Empereur F, Stoltz JF, Chabannon C. Bone Marrow Transplant; 2013 Apr 20; 48(4):604-9. PubMed ID: 23528642 [Abstract] [Full Text] [Related]
23. [Graft reinjection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Tarillon S, Andrianne C, Balcaen S, Bole S, Genty C, Godin S, Lemarchand E, Mouchebeuf J, Mussot I, Wallart A, Alsuliman T, Desbrosses Y, El Cheikh J, Guerout-Verite MA, De Vos J, Tardieu L, Yakoub-Agha I, Porcheron S. Bull Cancer; 2019 Jan 20; 106(1S):S83-S91. PubMed ID: 30528618 [Abstract] [Full Text] [Related]
24. Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program. Chabannon C, Pamphilon D, Vermylen C, Gratwohl A, Niederwieser D, McGrath E, Lamers C, Lanza F, Slaper-Cortenbach I, Madrigal A, Apperley J. Bone Marrow Transplant; 2012 Jan 20; 47(1):15-7. PubMed ID: 21383685 [Abstract] [Full Text] [Related]
25. Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation. Gratwohl A, Brand R, McGrath E, van Biezen A, Sureda A, Ljungman P, Baldomero H, Chabannon C, Apperley J, Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy and the European Group for Blood and Marrow Transplantation, and the European Leukemia Net. Haematologica; 2014 May 20; 99(5):908-15. PubMed ID: 24488562 [Abstract] [Full Text] [Related]
26. Kenyon M, Babic A, Charley C, Babic A, Arraut IB, Ferrero I. ; 2018 May 20. PubMed ID: 31314320 [Abstract] [Full Text] [Related]
27. Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: a cost analysis. Zahnd D, Leibundgut K, Zenhäusern R, Pabst T, Fontana S, Schneider R, Tobler A, Zwicky C. Bone Marrow Transplant; 2004 Nov 20; 34(10):847-53. PubMed ID: 15517005 [Abstract] [Full Text] [Related]
28. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation. Mueller MM, Seifried E. Transfus Clin Biol; 2006 Nov 20; 13(5):282-5; quiz 286-9. PubMed ID: 17196864 [Abstract] [Full Text] [Related]
29. Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow). Rosskopf K, Ragg SJ, Worel N, Grommé M, Preijers FW, Braakman E, Schuurhuis GJ, van Riet I, Wendel S, Fontão-Wendel R, Lazar A, Goldman M, Halpenny M, Giulivi A, Letcher B, McGann L, Korhonen M, Arvola A, Humpe A, Buwitt-Beckmann U, Wiesneth M, Schauwecker P, Schrezenmeier H, Bönig H, Henschler R, Seifried E, Accorsi P, Bonfini T, Takanashi M, van Beckhoven JM, Brand A, Gounder D, Wong A, Dooccey R, Forrest E, Galea G, Smythe J, Pawson R, Reems JA, Oh J, Reesink HW, Panzer S. Vox Sang; 2011 Oct 20; 101(3):255-75. PubMed ID: 21923889 [No Abstract] [Full Text] [Related]
30. Risk analysis of hematopoietic stem cell transplant process: failure mode, effect, and criticality analysis and hazard analysis critical control point methods integration based on guidelines to good manufacturing practice for medicinal product ANNEX 20 (February 2008). Gianassi S, Bisin S, Bindi B, Spitaleri I, Bambi F. Transplant Proc; 2010 Oct 20; 42(6):2252-3. PubMed ID: 20692457 [Abstract] [Full Text] [Related]
31. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D. Klin Padiatr; 2004 Oct 20; 216(6):356-63. PubMed ID: 15565551 [Abstract] [Full Text] [Related]
32. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G. Bone Marrow Transplant; 2006 Feb 20; 37(3):249-61. PubMed ID: 16435004 [Abstract] [Full Text] [Related]
33. JACIE: A 20 year-old voluntary body functioning worldwide. Yüksel MK, İlhan O. Transfus Apher Sci; 2018 Apr 20; 57(2):153-158. PubMed ID: 29801765 [Abstract] [Full Text] [Related]
34. Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Pession A, Rondelli R, Paolucci P, Pastore G, Dini G, Bonetti F, Madon E, Mandelli F, Zanesco L, Uderzo C, Prete A, Rabusin M, Ugazio A, Di Bartolomeo P, Favre C, Bojd-Faulkner L, Poggi V, Luksch R, Donfrancesco A, Argiolu F, La Nasa G, Amici A, Locatelli F. Haematologica; 2000 Jun 20; 85(6):638-46. PubMed ID: 10870122 [Abstract] [Full Text] [Related]
35. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Miano M, Labopin M, Hartmann O, Angelucci E, Cornish J, Gluckman E, Locatelli F, Fischer A, Egeler RM, Or R, Peters C, Ortega J, Veys P, Bordigoni P, Iori AP, Niethammer D, Rocha V, Dini G, Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant; 2007 Jan 20; 39(2):89-99. PubMed ID: 17213848 [Abstract] [Full Text] [Related]
36. The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications. de Vries EG, Vellenga E, Kluin-Nelemans JC, Mulder NH. Eur J Cancer; 2004 Sep 20; 40(13):1987-92. PubMed ID: 15315808 [Abstract] [Full Text] [Related]
37. Transplant of hematopoietic stem cells in childhood: where we are and where we are going. Locatelli F, Burgio GR. Haematologica; 1998 Jun 20; 83(6):550-63. PubMed ID: 9676029 [Abstract] [Full Text] [Related]
38. Joint position paper on the regulatory approach to hematopoietic cell components in the United States. J Hematother; 1997 Apr 20; 6(2):91-2. PubMed ID: 9131437 [No Abstract] [Full Text] [Related]
39. Regulation of hematopoietic stem cell processing and transplantation. Rowley SD. Int J Hematol; 2002 Apr 20; 75(3):237-45. PubMed ID: 11999350 [Abstract] [Full Text] [Related]
40. Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukaemia and myelodysplastic syndromes. Sebrango A, Vicuña I, de Laiglesia A, Millán I, Bautista G, Martín-Donaire T, Regidor C, Cabrera R, Fernandez MN. Best Pract Res Clin Haematol; 2010 Jun 20; 23(2):259-74. PubMed ID: 20837338 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]